Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report 2021 - 2028

 Actinic Keratosis Treatment Industry Overview

The global actinic keratosis treatment market size was valued at USD 5.78 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 4.3% from 2021 to 2028. The increasing prevalence of the disease coupled with an increasing geriatric population and rising awareness about the disease are factors expected to drive the growth over the forecast period. For instance, in the U.S. and Europe, the prevalence of the disease ranges from 11 to 26%, due to which it is the most commonly treated dermatologic disease in the outpatient setting in the U.S. Moreover, the prevalence is highest in Australia with an estimation of 37 to 55% in adults aged 40 years and above. However, the outbreak of COVID-19 has affected the market adversely.

The increasing global concern for the disease is a key market driver. According to the Skin Cancer Foundation, it is estimated that more than 58 million people are affected by one or more actinic keratosis in the U.S. Moreover, factors, such as severe baldness, old age, the high tendency of sunburn, and skin wrinkling, make a person more predisposed to develop the disease. Furthermore, patients in some regions, such as Australia and New Zealand, exhibit relatively more harmful effects of sun exposure than in other areas. The concerns related to the disease are increasing due to the growing patient base globally.

Gather more insights about the market drivers, restrains and growth of the Global Actinic Keratosis Treatment market

The COVID-19 pandemic has adversely affected the global market. In 2020, the diagnosis and treatment rates have been reduced significantly due to restrictions on non-essential doctor visits and complete lockdown in most countries. For instance, in 2020, around 12.7 million treatments including surgical, photodynamic therapy, and topical drugs for actinic keratosis were performed in the U.S. whereas, in 2019, there were around 15.1 million treatments for actinic keratosis. Moreover, the American Academy of Dermatology was continuously communicating with dermatologists to restrict the visit of patients with non-urgent medical conditions including actinic keratosis.

An increasing number of drug approvals and the expected launch of novel therapies for the disease are expected to propel the growth. For instance, in December 2020, Almirall, S.A. received the U.S. FDA approval for Klisyri (tirbanibulin) for the treatment of actinic keratosis of the face and scalp. Moreover, in June 2020, Sun Pharmaceutical Industries Ltd. launched Levulan Kerastick, a topical solution for the treatment of mild to moderate actinic keratosis of the scalp, face, and upper extremities. The expected increase in the adoption owing to the commercialization of novel drugs coupled with the associated cost is one of the factors anticipated for the market growth.

The growing research & development activities are expected to increase the approval of novel drugs for the treatment of actinic keratosis over the forecast period. Pipeline candidates in the late phase of clinical trials, such as KX2-391, SOR007, AM001, and others, are expected to drive market growth. Moreover, the high risk of developing skin cancer from actinic keratosis has resulted in an increased diagnosis & treatment rate. According to the Skin Cancer Foundation, untreated precancerous skin growths can develop into squamous cell carcinoma. About 10% of untreated actinic keratosis becomes cancerous and the majority of skin cancers start as actinic keratosis.


Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

  • Gaucher Disease Drugs Market - The global gaucher disease (GD) drugs market size was valued at USD 1.55 billion in 2017. It is anticipated to expand at a CAGR of 1.1% during the forecast period. Gaucher disease is an autosomal recessive metabolic disorder, with an average prevalence of 1 in 100,000 individuals. It is the most common lysosomal storage disorder.

  • Blockbuster Oncology Brands Market - The global blockbuster oncology brands market size was valued at USD 28.75 billion in 2017. Heightened adoption of cancer immunotherapies in developed regions along with continual expansion of indications with accelerated approvals granting these therapies first-line treatment status is poised to drive the market during the forecast period.

 

Actinic Keratosis Treatment Market Segmentation

Grand View Research has segmented the global actinic keratosis treatment market on the basis of therapy, drug class, end-use, and region:

Actinic Keratosis Treatment Therapy Outlook (Revenue, USD Million, 2017 - 2028)

  • Topical
  • Surgery
  • Photodynamic Therapy

 

Actinic Keratosis Treatment Drug Class Outlook (Revenue, USD Million, 2017 - 2028)

  • Nucleoside Metabolic Inhibitor
  • NSAIDs
  • Immune Response Modifiers
  • Photoenhancers
  • Others

 

Actinic Keratosis Treatment End-use Outlook (Revenue, USD Million, 2017 - 2028)

  • Hospitals
  • Private Clinics
  • Homecare
  • Others

 

Actinic Keratosis Treatment Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Key Companies profiled:

Some prominent players in the global Actinic Keratosis Treatment market include

  • Sun Pharmaceutical Industries Ltd.
  • Novartis AG
  • GALDERMA
  • Hill Dermaceuticals, Inc.
  • Viatris Inc.
  • Mylan N.V.
  • Bausch Health Companies, Inc.
  • LEO Pharma A/S
  • Almirall, S.A.
  • Biofrontera AG
  • 3M

 

Order a free sample PDF of the Actinic Keratosis Treatment Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more